1. Medtech Insight
  2. >>Archive

New Directions for Robotic Surgery

Medical robotics has changed dramatically since the 1980s, when neurosurgeons first used a robot to precisely hold a fixture during brain surgery. Advances in computer image processing, surgical imaging technologies, techniques for registering surgical images, modeling, mechatronics, surgical simulation, and human-robot interaction have opened the door for emerging technologies that will have an increasing impact on growth in this market for many years to come.

by Anne Staylor

Medical robotics is a dynamic field that is advancing rapidly as manufacturers develop robotic technologies for a growing number of health-related tasks. Today, hospitals, patients, and clinicians are using robotic...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Medtech Insight

Swiss Medtechs Advised To Work On US Tariff Mitigation Strategies

 
• By Ashley Yeo

The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.

Guardant Health Launches Germline Hereditary Cancer Test

 
• By Natasha Barrow

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.

FDLI: Clinical Labs Face Uncertainty After Texas Court’s LDT Ruling

 
• By Elizabeth Orr

A Texas court's decision against US FDA regulation of lab-developed tests (LDTs) has introduced new uncertainties for clinical labs. Industry stakeholders are now worried about potential future regulations while also managing existing compliance requirements. Recent conference discussions underscored the complexities of FDA oversight.